Literature DB >> 16359196

Group A Streptococci from carriage and disease in Portugal: evolution of antimicrobial resistance and T antigenic types during 2000-2002.

R Pires1, D Rolo, L Gama-Norton, A Morais, L Lito, M J Salgado, C Johansson, G Möllerberg, B Henriques-Normark, J Gonçalo-Marques, I Santos-Sanches.   

Abstract

In this study, we analyzed the antimicrobial resistance properties and T antigenic types of 511 isolates collected in Lisbon district, Portugal, from throat swabs of healthy subjects (n=341), during 2000-2002 and from diverse infection sites (n=170) of outpatients and inpatients, during 1999-2002. Erythromycin resistance was higher in tonsillitis/pharyngitis (27.4%) and skin infection isolates (21.1%), than in carriage and invasive isolates (<or=10%). Differences in erythromycin resistance among children and adults were noticed only for carriage isolates (9.3% in children and 21.1% in adults). Most erythromycin-resistant isolates from carriage (82.4%) and tonsillitis/pharyngitis (71.9%) showed the M phenotype. All M phenotype isolates (n=53) carried mef(A), whereas all MLS(B) phenotype isolates (n=19) carried erm(B) and not erm(A). Resistance to tetracycline [mediated by tet(M) in most isolates] was <or=6% in tonsillitis/pharyngitis and carriage isolates, 36.8% in skin infection isolates, and 44.1% in invasive isolates. The M phenotype increased since 2000, linked to a decrease of tetracycline resistance, and was predominantly associated with T1 in 2000-2001 and T12 in 2002 among carriage isolates, and with T8/25/Imp19 through 2000-2002 among tonsillitis/pharyngitis isolates. The majority (53%) of the tetracycline-resistant invasive isolates were nontypable. All isolates were susceptible to penicillin and chloramphenicol. This study showed that tetracycline and macrolide resistance frequency and phenotypes differ among GAS from various origins and changed over time. Moreover, T typing suggested that most drug-resistant isolates causing oropharyngeal carriage are distinct from the majority of isolates causing noninvasive and invasive infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16359196     DOI: 10.1089/mdr.2005.11.360

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  10 in total

1.  Nonoutbreak surveillance of group A streptococci causing invasive disease in Portugal identified internationally disseminated clones among members of a genetically heterogeneous population.

Authors:  A Friães; M Ramirez; J Melo-Cristino
Journal:  J Clin Microbiol       Date:  2007-04-25       Impact factor: 5.948

2.  Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.

Authors:  Renato Pires; Carmen Ardanuy; Dora Rolo; Ana Morais; António Brito-Avô; José Gonçalo-Marques; Josefina Liñares; Ilda Santos-Sanches
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

3.  Description of macrolide-resistant and potential virulent clones of Streptococcus pyogenes causing asymptomatic colonization during 2000-2006 in the Lisbon area.

Authors:  R Pires; D Rolo; A Morais; A Brito-Avô; C Johansson; B Henriques-Normark; J Gonçalo-Marques; I Santos-Sanches
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-21       Impact factor: 3.267

4.  In vitro activities of retapamulin and 16 other antimicrobial agents against recently obtained Streptococcus pyogenes isolates.

Authors:  Emilio Pérez-Trallero; Esther Tamayo; Milagrosa Montes; José M García-Arenzana; Victor Iriarte
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

5.  Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004.

Authors:  Bogdan Luca-Harari; Kim Ekelund; Mark van der Linden; Margit Staum-Kaltoft; Anette M Hammerum; Aftab Jasir
Journal:  J Clin Microbiol       Date:  2007-10-24       Impact factor: 5.948

Review 6.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

7.  Biofilm production and other virulence factors in Streptococcus spp. isolated from clinical cases of bovine mastitis in Poland.

Authors:  Edyta Kaczorek; Joanna Małaczewska; Roman Wójcik; Andrzej Krzysztof Siwicki
Journal:  BMC Vet Res       Date:  2017-12-28       Impact factor: 2.741

8.  Molecular Cloning and Docking of speB Gene Encoding Cysteine Protease With Antibiotic Interaction in Streptococcus pyogenes NBMKU12 From the Clinical Isolates.

Authors:  Natesan Balasubramanian; Govintharaj Varatharaju; Vellasamy Shanmugaiah; Karuppiah Balakrishnan; Mandayam A Thirunarayan
Journal:  Front Microbiol       Date:  2018-08-07       Impact factor: 5.640

9.  Human group A streptococci virulence genes in bovine group C streptococci.

Authors:  Márcia G Rato; Ricardo Bexiga; Sandro F Nunes; Cristina L Vilela; Ilda Santos-Sanches
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

10.  New Insights on Streptococcus dysgalactiae subsp. dysgalactiae Isolates.

Authors:  Cinthia Alves-Barroco; João Caço; Catarina Roma-Rodrigues; Alexandra R Fernandes; Ricardo Bexiga; Manuela Oliveira; Lélia Chambel; Rogério Tenreiro; Rosario Mato; Ilda Santos-Sanches
Journal:  Front Microbiol       Date:  2021-07-15       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.